Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.00
+0.0050 (0.22%)
Apr 29, 2026, 10:09 AM EDT - Market open
Jin Medical International Revenue
In the fiscal year ending September 30, 2025, Jin Medical International had annual revenue of $20.69M, down -11.98%. Jin Medical International had revenue of $10.81M in the half year ending September 30, 2025, with 12.93% growth.
Revenue (ttm)
$20.69M
Revenue Growth
-11.98%
P/S Ratio
0.87
Revenue / Employee
$75,778
Employees
273
Market Cap
18.00M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 86.55M |
| Retractable Technologies | 38.27M |
| Bionano Genomics | 28.51M |
| Precision Optics Corporation | 24.42M |
| Nephros | 18.79M |
| Ekso Bionics Holdings | 12.80M |
| Milestone Scientific | 8.97M |
| Lucyd | 2.66M |
ZJYL News
- 22 days ago - Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement - PRNewsWire
- 6 weeks ago - Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative - PRNewsWire
- 2 months ago - Jin Medical CEO Fireside Chat - PRNewsWire
- 3 months ago - Jin Medical International Ltd. To Host Management Fireside Chat - PRNewsWire
- 3 months ago - Jin Medical Announces the Official Commencement Date of Chuzhou Facility - PRNewsWire
- 10 months ago - Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility - GlobeNewsWire
- 1 year ago - Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance - GlobeNewsWire
- 1 year ago - Construction of JinMed's New Facility Begins in Chuzhou, China - GlobeNewsWire